Details for New Drug Application (NDA): 050497
✉ Email this page to a colleague
NDA 050497 describes TICAR, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the TICAR profile page.
The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.
The generic ingredient in TICAR is ticarcillin disodium. There are five drug master file entries for this compound. Additional details are available on the ticarcillin disodium profile page.
Summary for 050497
| Tradename: | TICAR |
| Applicant: | Glaxosmithkline |
| Ingredient: | ticarcillin disodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050497
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 6GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
